MSD Animal Health, a division of Merck & Co., has signed an agreement to acquire Scan Aqua AS, a company that develops, registers and markets products for the European aquaculture industry.
Scan Aqua's product portfolio includes the key products AQUI-S and Finquel. AQUI-S is a calming agent used during treatment, pumping, transportation and handling of salmon and rainbow trout. Finquel is an anesthetic that is widely used in fish farming during the vaccination process and other handling events that require the fish to be fully anesthetized, such as lice counting.
Alpha Corporate Finance has acted as financial advisor to the owners of Scan Aqua.
MSD Animal Health is the global animal health business unit of Merck & Co., a leading global biopharmaceutical company. MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets.
Scan Aqua is the aquaculture subsidiary of the Norwegian privately held company Scanvacc AS.